Pe­ter Thiel-backed psy­che­delics play­er ATAI pulls in an­oth­er nine-fig­ure raise. But they're not ready to talk IPO — yet

Rough­ly three and a half months since its last fundrais­ing round, the Pe­ter Thiel-backed ATAI Life Sci­ences has pulled in its lat­est ven­ture haul.

The com­pa­ny closed a $157 mil­lion Se­ries D round ear­ly Wednes­day as it press­es the gas on its psy­che­delics-based strat­e­gy. Though the short time be­tween the two rais­es will like­ly fu­el spec­u­la­tion about a po­ten­tial jump to Nas­daq, ATAI isn’t ready to talk about that just yet, pre­emp­tive­ly de­clin­ing com­ment on all IPO-re­lat­ed ques­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER